Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review).

References

• Cannon WB: Bodily Changes in Pain, Hunger, Fear, and Rage. New York: Publ Appleton Century, 1920.
   Google Scholar
• Raab W: Cardiotoxic effects of emotional, socioeconomic, and environmental stresses. In Bajusz E, Rona G (eds): “Recent Advances In Studies On Cardiac Structure And Metabolism I, Myocardiology”, Baltimore: University Park Press, pp 707–713, 1972.
   Google Scholar
• Raab W: Sudden death of a young athlete with an excessive concentration of epinephrine-like substances in the heart muscle. Arch Path 36: 488–492, 1943.
   Google Scholar
• Raab W: Myocardial electrolyte derangement: crucial feature of pluricausal so-called coronary heart disease. Ann NY Acad Sci 147: 629–686, 1969.
   Google Scholar
• Braunwald E, Harrison DC, Chidsey CA: The heart as an endocrine organ. (Editorial) Am J Med 36: 1–4, 1964.
   Google Scholar
• Shahab L, Wollenberger A, Krause EG, Genz S: Effect of acute ischaemia on catecholamines and cyclic AMP levels in normal and hypertrophied myocardium. In Oliver MF, Julian DG, Donald KW (eds): “Effect of Acute Ischemia On Myocardial Function.” London: Churchill Livingstone Press, pp 97–107, 1972.
   Google Scholar
• Mason JW, Mangan G, Brady JV, Conrad D, Rioch D McK: Concurrent plasma epinephrine, norepinephrine, and 17-hydroxycorticosteroid levels during conditioned emotional disturbances in monkeys. Psychosom Med 23: 344–000, 1961.
   Google Scholar
• Basowitz H, Persky H, Korchin SJ, Grinker RR: Anxiety and Stress. New York: Blakiston Div, McGraw-Hill Book Co, 1955.
   Google Scholar
• Persky H: Adrenocortical function during anxiety. In Roessler R, Greenfield NS (eds): Physiologic Correlates of Psychological Disorders, Madison, WI: Univ of Wisconsin Press 1962.
   Google Scholar
• Golf SW, Happel O, Graef V, Seim KE: Plasma aldosterone, Cortisol and electrolyte concentrations in physical exercise after magnesium supplementation. J Clin Chem Clin Biochem 22: 717–721, 1984.
   PubMedGoogle Scholar
• Douglas WW, Rubin RP: The effects of alkaline earths and other divalent cations on adrenal medullary secretion. J Physiol 175: 231–241, 1964.
   PubMed Web of Science ®Google Scholar
• Boullin DJ: The action of extracellular cations on the release of the sympathetic transmitter from peripheral nerves. J Physiol 189: 85–99, 1967.
   Google Scholar
• Kirpekar SM, Misu Y: Release of noradrenalin by splenic nerve stimulation and its dependence on calcium. J Physiol 188: 219–234, 1967.
   PubMed Web of Science ®Google Scholar
• Euler US, Lishajko F: Effects of Mg2+ and Ca2+ on noradrenaline release and uptake in adrenergic nerve granules in different media. Acta Physiol Scand 89: 415–422, 1973.
   PubMedGoogle Scholar
• Baker PF, Rink TJ: Catecholamine release from bovine adrenal medulla in response to maintained depolarization. J Physiol 253: 593–620, 1975.
   Google Scholar
• Iseri LT, French JH: Magnesium: nature's physiologic calcium blocker. Am Heart J 108: 188–193, 1984.
   PubMed Web of Science ®Google Scholar
• Whyte KF, Addis GJ, Whitesmith R, Reid JL: Adrenergic control of plasma magnesium in man. Clin Sci 72: 135–138, 1987
   PubMed Web of Science ®Google Scholar
• Johansson BW, Juul-Moller S, Ruter G, Soes-Pedersen U: Effect of i.v. adrenaline infusion on serum electrolytes, including S-Mg. Magnesium Bull 8: 259–260, 1986.
   Google Scholar
• Joborn H, Akerstrom G, Ljunghall S: Effects of exogenous catecholamines and exercise on plasma magnesium concentrations. Clin Endocrinol Oxford 23: 219–226, 1985.
   PubMed Web of Science ®Google Scholar
• Fletcher GF, Sweeney ME, Fletcher BJ: Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade. Am Heart J 121(Pt 1)):105–110, 1991.
   Google Scholar
• James MF: Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics. Br J Anaesth 62: 616–623, 1989.
   PubMed Web of Science ®Google Scholar
• James MF, Beer RE, Esser JD: Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation. Anesth Analg 68: 772–776, 1989.
   Web of Science ®Google Scholar
• Milewicz A: An attempt at evaluation magnesium metabolism in experimental hyperadrenalaemia in rabbits and in cases of phaeochromocytoma treated surgically. Materia Med Pol 4: 267–271, 1978.
   Google Scholar
• Cohen L, Kitzes R: Pheochromocytoma - a rare cause of hypermagnesemia. Magnesium 4: 165–167, 1985.
   Google Scholar
• Balazs T: Cardiotoxicity of isoproterenol in experimental animals. Influence of stress, obesity and repeated dosing. In Bajusz E, Rona G (eds): “Recent Advances In Studies on Cardiac Structure and Metabolism. I. Myocardiology.” Baltimore: University Park Press, pp 770–778, 1972.
   Google Scholar
• Franz KB, Rueddel H, Todd GL, Dorheim TA, Buell JC, Eliot RS: Physiologic changes during a marathon, with special reference to magnesium. J Am Coll Nutr 4: 187–194, 1985.
   PubMed Web of Science ®Google Scholar
• Lutwak L, Hurt C, Reid JM: Effect of corticoids on magnesium metabolism in man. Clin Res 9: 184, 1961.
   Google Scholar
• Hanna S, MacIntyre: The influence of aldosterone on magnesium metabolism. Lancet 2: 348–350, 1960.
   PubMed Web of Science ®Google Scholar
• Care AD, Ross DB: The role of the adrenal cortex in magnesium homeostasis in the aetiology of hypomagnesaemia. Res Vet Sci 4: 24–63, 1963.
   Google Scholar
• Mader IJ, Iseri LT: Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of cor-ticosterone-like mineralocorticoid. Am J Med 19: 976–988, 1955.
   PubMedGoogle Scholar
• Horton R, Biglieri EG: Effect of aldosterone on the metabolism of magnesium. J Clin Endocrin Metab 22: 1187–1192, 1962.
   PubMed Web of Science ®Google Scholar
• Cantin M: Relationship of juxtaglomerular apparatus and adrenal cortex to biochemical and extracellular fluid volume changes in magnesium deficiency. Lab Invest 22: 558–568, 1970.
   PubMed Web of Science ®Google Scholar
• Care AD, McDonald IR: Plasma magnesium concentration as a possible factor in the control of aldosterone secretion. Biochem J 87: 2P–3P, 1963.
   Google Scholar
• Ryan MP, Ryan MF, Counihan TB: The effect of diuretics on lymphocyte magnesium and potassium. Acta Med Scandinav Suppl 647: 153–161, 1981.
   PubMedGoogle Scholar
• Widman L, Dyckner T, Wester PO: Effect of moduretic and aldactone on electrolytes in skeletal muscle in patients on long-term diuretic therapy. Acta Med Scandinav Suppl 661: 33–35, 1982.
   Google Scholar
• Bajusz E, Selye H: Conditioning factors for cardiac necrosis. Trans N Y Acad Sci Ser II 1: 659–667, 1959.
   Google Scholar
• Chappel CI, Rona G, Gaudry R: The influence of adrenal cortical steroids on cardiac necrosis produced by isoproterenol. Acta Endocr 32: 419–424, 1959.
   Google Scholar
• Bajusz E: The terminal electrolyte-shift mechanism in heart muscle; its significance in the pathogenesis and prevention of necrotizing cardiomyopathies. In Bajusz E (ed): Electrolytes and Cardiovascular Disease. I. Fundamental Aspects. Baltimore: Williams & Wilkins Press, pp 274–322, 1965.
   Google Scholar
• Rona G, Kahn S, Chappel CI: The effect of electrolytes on experimental infarct-like myocardial necrosis. IBID, pp 181–191.
   Google Scholar
• Lehr D: The role of certain electrolytes and hormones in disseminated myocardial necrosis. IBID, pp 248–273.
   Google Scholar
• Selye H: The evolution of the stress concept. Am J Cardiol 26: 289–299, 1970.
   PubMedGoogle Scholar
• Seelig MS, Heggtveit HA: Magnesium interrelationships in ischemic heart disease. A review. Am J Clin Nutr 27: 59–79, 1974.
   PubMed Web of Science ®Google Scholar
• Vormann J, Guenther T, Leder O: Effect of isoproterenol and phenylephrine on the heart of normal and Mg-deficient rats. Magnesium Bull 3: 130–134, 1981.
   Google Scholar
• Guenther T: Cardiovascular biochemistry. Magnesium Bull 8: 136–144, 1986.
   Google Scholar
• Vormann J, Fischer G, Classen HG, Thoni H: Influence of decreased and increased magnesium supply on the cardiotoxic effects of epinephrine in rats. Arzneimittel forschung 33: 205–210, 1983.
   Google Scholar
• Ebel H, Guenther T: Role of magnesium in cardiac disease. J Clin Chem Clin Biochem 21: 249–265, 1983.
   PubMedGoogle Scholar
• Classen HG, Fischer G, Jacob R, Marx J, Schimatschek H, Stein C: Prenecrotic electrolyte alterations of the adrenergic cardiopathy: Potentiation by magnesium depletion and prevention by high dietary magnesium levels and verapamil. Magnesium Bull 8: 82–92, 1986.
   Google Scholar
• Bloom S: Effects of magnesium deficiency on the pathogenesis of myocardial infarction. Magnesium 5: 154–164, 1986.
   Google Scholar
• Bloom S: Magnesium deficiency cardiomyopathy. Am J Cardiovasc Pathol 2: 7–17, 1988.
   Google Scholar
• Vormann J, Forster R, Guenther T, Ebel H: Lipolysis-induced magnesium uptake into fat cells. Magnesium Bull 5: 39–41, 1983.
   Google Scholar
• Rayssiguier Y: Hypomagnesemia resulting from adrenaline infusion in ewes: its relation to lipolysis. Horm Metab Res 9: 309–314, 1977.
   PubMed Web of Science ®Google Scholar
• Flink EB, Shane SR, Scobbo RR, Blehschmidt NG, McDowell P: Relationship of free fatty acids and magnesium in ethanol withdrawal in dogs. Metabolism 28: 858–865, 1979.
   PubMed Web of Science ®Google Scholar
• Oliver MF, Kurien VA, Greenwood TW: Relation between serum free fatty acids and arrhythmias and death after acute myocardial infarction. Lancet 1: 710–715, 1962.
   Google Scholar
• Opie LH: Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol 36: 938–953, 1975.
   PubMed Web of Science ®Google Scholar
• Flink EB, Brick JE, Shane SR: Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med 141: 441–443, 1981.
   PubMedGoogle Scholar
• Henrotte JG, Plouin PF, Levy-Leboyer C, Moser G, Sidoroff-Girault N, Franck G, Santarromana M, Pineau M: Blood and urinary magnesium, zinc, calcium, free fatty acids, and catecholamines in type A and type B subjects. J Am Coll Nutr 4: 165–172, 1985.
   PubMed Web of Science ®Google Scholar
• Pratt K, Moody ML, Cinlee RK, Rueddel H, Franz KB: Changes in serum free fatty acids and magnesium during a marathon. Magnesium 4: 207–208, 1985.
   Google Scholar
• Durlach J: [Physiologic antithrombotic role of magnesium. Concerning magnesium deficient phlebothrombotic disease.] Coeur Med Interne 6: 213–232, 1967. (in French)
   PubMedGoogle Scholar
• Seelig MS: “Magnesium Deficiency in The Pathogenesis of Disease. Early Roots of Cardiovascular, Skeletal, and Renal Abnormalities”. New York: Plenum Medical Book Co, 1980.
   Google Scholar
• Kurgan A, Gertz D, Wajnberg RS, Eldor A, Jersky J, Nelson E: Effect of magnesium sulfate on platelet deposition in rabbits following temporary arterial occlusion with surgical clips. Surgery 87: 390–396, 1980.
   PubMedGoogle Scholar
• Gertz SD, Wajnberg RS, Kurgan A, Uretzky G: Effect of magnesium sulfate on thrombus formation following partial arterial constriction: implications for coronary vasospasm. Magnesium 6: 225–235, 1987.
   PubMedGoogle Scholar
• Sos J: An investigation into the nutritional factors of experimental cardiopathy. In Bajusz E (ed): “Electrolytes And Cardiovascular Disease I. Fundamental Aspects”. Baltimore: Williams & Wilkins Press, pp 161–180, 1965.
   Google Scholar
• Rigo J: The relationship between magnesium and the vascular system. In Durlach J (ed) “Proc 1st Intl Mg Sympos, Vittel, France I”. pp 215–228, 1971.
   Google Scholar
• Rishi M, Ahmad A, Makheja A, Karcher D, Bloom S: Effects of reduced dietary magnesium on platelet production and function in hamsters. Lab Invest 63: 717–721, 1990.
   Google Scholar
• Seelig MS: Increased need for magnesium with the use of combined oestrogen and calcium for osteoporosis treatment. Magnesium Res 3: 197–215, 1990.
   PubMedGoogle Scholar
• Seelig MS: Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome. J Am Coll Nutr 12: 442–458, 1993.
   PubMed Web of Science ®Google Scholar
• Nigam S, Averdunk R, Guenther T: Alteration of prostanoid metabolism in rats with magnesium deficiency. Prostaglandins Leukotrienes Med 23: 1–10, 1986.
   PubMedGoogle Scholar
• Nadler JL, Goodson S, Rude RK: Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 9: 379–383, 1987.
   PubMed Web of Science ®Google Scholar
• Nadler J, Kuong H, Ehrlich L, Ryzen E, Frances R, Rude R: Magnesium plays an important role in the regulation of thromboxane release and platelet aggregation. 1989 Natl Mtg of Am Fed Clin Res, Washington DC, 1989.
   Google Scholar
• Nadler J, Ilwang D, Yen C, Rude R: Magnesium plays a key role in inhibiting platelet aggregation and release reaction. Am Heart Assoc Sci Session, Anaheim CA, 1991.
   Google Scholar
• Woods KL: Possible pharmacological actions of magnesium in acute myocardial infarction. Brit Clin Pharmacol 32: 3–10, 1991.
   PubMed Web of Science ®Google Scholar
• Altura BM, Altura BT, Waldemar Y: Effects of magnesium on prostaglandin responses in arterial and venous smooth muscle. In Cantin M, Seelig MS (eds): “Magnesium in Health And Disease”. (Proc of 2nd Intl Mg Sympos, Quebec, 1976) New York: Spectrum Press, pp 687–694, 1980.
   Google Scholar
• Bergman G, Daly K, Atkinson L, Rothman M, Richardson PJ, Jackson G, Jewett DE: Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease. Lancet 1: 569–572, 1981.
   PubMed Web of Science ®Google Scholar
• Briel RC, Lippert TH, Zahradnik HP: [Changes in blood coagulation, thrombocyte function and vascular prostacyclin synthesis caused by magnesium sulfate]. Geburtsh Frauenheilkd 47: 332–336, 1987. (in German)
   PubMed Web of Science ®Google Scholar
• Watson KV, Moldow CF, Ogburn PL, Jacob HS: Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci USA 83: 1075–1078, 1986.
   PubMed Web of Science ®Google Scholar
• Mak IT, Weglicki WB: Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circulation Res 66: 1449–1452, 1990.
   PubMed Web of Science ®Google Scholar
• Weglicki WB, Mak IT, Simic MG: Mechanisms of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 22: 1199–1208, 1990.
   PubMed Web of Science ®Google Scholar
• Freedman AM, Atrakchi AH, Cassidy MM, Weglicki WB: Magnesium deficiency-induced cardiomyopathy: protection by vitamin E. Biochem Biophys Res Commun 170: 1102–1106, 1990.
   PubMed Web of Science ®Google Scholar
• Freedman AM, Cassidy MM, Weglicki WB: Magnesium-deficient myocardium demonstrates an increased susceptibility to an in vivo oxidative stress. Magnes Res 4: 185–189, 1991.
   PubMedGoogle Scholar
• Weglicki WB, Freedman AM, Bloom S, Atrakchi, AHTM, Cassidy MM, Dickens BJ: Antioxidants and the cardiomyopathy of Mg Deficiency. Am J Cardiovasc Path 4: 210–215, 1992.
   PubMedGoogle Scholar
• Mak IT, Boehme P, Weglicki WB: Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Circulation Res 70: 1099–1103, 1992.
   PubMed Web of Science ®Google Scholar
• Atrakchi A, Weglicki W B, Bloom S: Beta blockers protects against magnesium-deficiency-induced cardiac injury. FASEB J 3: A921, 1989.
   Google Scholar
• Atrakchi AH, Bloom S, Dickens BF, Mak IT, Weglicki WB: Hypomagnesemia and isoproterenol cardiomyopathies: protection by probucol. Cardiovasc Pathol 1: 155–160, 1992.
   PubMedGoogle Scholar
• Singal PK, Kapur N, Dillon KS, Beamish RE, Dhalla NS: Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 60: 1390–1397, 1982.
   PubMed Web of Science ®Google Scholar
• Singh RB, Rastogi SS, Ghosh S, Niaz MA: Dietary and serum magnesium levels in patients with acute myocardial infarction, coronary artery disease and noncardiac diagnoses. J Am Coll Nutr 13: 139–143, 1994.
   PubMed Web of Science ®Google Scholar
• Singh RB, Sircar AR, Rastogi SS, Garg V: An Indian experiment with nutritional modulation in acute myocardial infarction. Am J Cardiol 69: 879–885, 1992.
   PubMed Web of Science ®Google Scholar
• Whang R, Wagner R: The influence of venous occlusion and exercise on serum magnesium concentration. Metabolism 15: 608–612, 1966.
   PubMed Web of Science ®Google Scholar
• Engel RR, Elin RJ: Hypermagnesemia from birth asphyxia, J Pediatrics 77: 631–637, 1970.
   Google Scholar
• Nayler WG: The heart cell: some metabolic aspects of cardiac arrhythmias. Acta Med Scand Suppl 647: 17–31, 1981.
   Google Scholar
• Van Vliet PD, Burchell HB, Titus JL: Focal myocarditis associated with pheochromocytoma. N Engl J Med 27: 1102–1108, 1966.
   Google Scholar
• Ferrans VJ, Hibbs RG, Cipriano PR, Buja LM: Histochemical and electron microscopic studies of norepinephrine-induced myocardial necrosis in rats. In Bajusz E, Rona G (eds): Recent Advances In Studies On Cardiac Structure And Metabolism. I, Myocardiology”. Baltimore: University Park Press, pp 495–525, 1972.
   Google Scholar
• Lehr D, Blaiklock R, Brown A, Dapson S: Magnesium loss as a reliable indicator of acute myocardial injury. In Cantin M, Seelig MS (eds): Magnesium In Health And Disease, (Proc of 2nd Intl Mg Sympos, Quebec, 1976), New York: Spectrum Press, pp 499–506, 1980.
   Google Scholar
• Smetana R, Brichta A, Glogar D, Meisinger V, Gotsauner-Wolf M, Spona J: Magnesium profile under stress conditions in coronary artery disease. Magnesium Res 2: 41–42, 1989
   Google Scholar
• Jenkins CD: The coronary prone personality. In Gentry W (ed): “Psychological Aspects of Aspects of Myocardial Infarction And Coronary Care”. St Louis: CV Mosby Press, pp 5–21, 1975.
   Google Scholar
• Henrotte JG: Type A behavior and magnesium metabolism. Magnesium 5: 201–210, 1986.
   Google Scholar
• Henrotte JG: Recent advances on genetic factors regulating blood and tissue magnesium concentrations; relationship with stress and immunity. In Itokawa Y, Durlach J (eds): Magnesium In Health And Disease. London: John Libbey Press, pp 285–289, 1989.
   Google Scholar
• Durlach J: “Magnesium In Clinical Practice” (transl by D Wilson). London: John Libbey & Co, 1988.
   Google Scholar
• Fehlinger R: Therapy with magnesium salts in neurological diseases. A critical appraisal. Magnesium Bull 12: 35–42, 1990.
   Google Scholar
• Durlach J, Durlach V: Idiopathic mitral valve prolapse and magnesium. State of the art. Magnesium Bull 8: 156–169, 1986.
   Google Scholar
• Galland LD, Baker SM, McLellan RK: Magnesium deficiency in the pathogenesis of mitral valve prolapse. 5: 165–174, 1986.
   Google Scholar
• Schimatschek HF, Hickl R, Classen HG: [Magnesium, calcium, and phosphorus levels in the serum of children with functional disorders. Preliminary data of a multicenter epidemiologic study with special emphasis on magnesium.] Magnesium Bull 10: 105–113, 1988. (in German)
   Google Scholar
• Schroeder HA: Hypertensive Diseases. Causes And Control. Philadelphia Lea & Febiger Press, 1953.
   Google Scholar
• Resnick LM, Laragh JH, Sealey JE, Alderman MH: Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium and plasma renin activity. N Engl J Med 309: 888–891, 1983.
   PubMed Web of Science ®Google Scholar
• Resnick LM, Gupta RK, Laragh JH: Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acad Sci USA 81: 6511–6515, 1984.
   PubMed Web of Science ®Google Scholar
• Resnick LM, Laragh JH: Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy. Am J Cardiol 56: 68H–74H, 1985.
   PubMed Web of Science ®Google Scholar
• Resnick L, Gupta R, Gruenspan H, Laragh J: Does decreased intracellular free magnesium mediate the peripheral insulin resistance of hypertension and obesity? Endocr Soc Sympos, 1988.
   Google Scholar
• Resnick LM, Gupta RK, Sosa RE, Corbett ML, Sealey JE, Laragh JH: Effects of altered dietary calcium intake in experimental hypertension - Role of intracellular free magnesium. J Hypertension 4 (Suppl 5):S182-S185, 1986.
   Google Scholar
• Rueddel H, Baehr M, Schaechinger H, Schmieder R, Ising G: Positive effects of magnesium supplementation in patients with labile hypertension and low magnesium concentration. Magnesium Bull 11: 93–98, 1989.
   Google Scholar
• Kuti V: A study of some clinical effects of chronic Mg supplementation in humans. Magnesium Res 2: 229, 1989.
   Google Scholar
• Food and Nutrition Board, Natl Res Council: “Recommended Dietary Allowances 10th Ed. Washington, DC: Natl Acad Press, pp 187–194, 1989.
   Google Scholar
• Raab W, Schroeder G, Wagner R, Gigee W, Adams MC, Diorio NG, Feely DA, Starczewski YK, White P: Vascular reactivity and electrolytes in normal and toxemic pregnancy. J Clin Endocrin Metab 16: 1196–1216, 1956.
   Web of Science ®Google Scholar
• Zuspan FP: Adrenal gland and sympathetic nervous system response in eclampsia. Am J Obstet Gynecol 114: 304–313, 1972.
   PubMed Web of Science ®Google Scholar
• Seelig MS, Altura BT, Resnick LM, Handwerker SM, Altura BM: Low magnesium, a common denominator in pathologic processes in diabetes mellitus, cardiovascular disease, and eclampsia. (Abstract) J Am Coll Nutr 11: 608, 1992.
   Google Scholar
• Weaver K: A possible anticoagulant effect of magnesium in pre-eclampsia. In Cantin M, Seelig MS (eds): “Magnesium in Health And Disease”. (Proc of 2nd Intl Mg Sympos, 1976) New York: Spectrum Press, pp 833–838, 1980.
   Google Scholar
• Weaver K: Pregnancy-induced hypertension and low birth weight in magnesium-deficient ewes. Magnesium 5: 191–200, 1986.
   PubMedGoogle Scholar
• Weaver K: Magnesium and fetal growth. Tr Subst in Environm Health 22: 136–142, 1988.
   Google Scholar
• Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK: Preeclampsia: endothelial cell disorder. Am J Obstet Gynecol 161: 1200–1204, 1989.
   PubMed Web of Science ®Google Scholar
• Calvin S, Weinstein L, Witte MH, Finley PR: Plasma levels of fibronectin and prostacyclin metabolite in peripartum preeclamptic women. Am J Perinatal 7: 125–129, 1990.
   PubMed Web of Science ®Google Scholar
• Massow S, Fehlinger R, Seidel K, Hecht K, Glatzel E: [Influence of sub-optimal Mg of rats during gestation and lactation on stress sensitivity of their adult offspring.] Magnesium Bull 4: 182–188, 1982. (in German)
   Google Scholar
• Miller JK, Schneider MD, Ramsey N, White PK, Bell MC: Effects of hypomagnesemia on reactivity of bovine and ovine platelets: possible relevance to infantile apnea and sudden infant death syndrome. J Am Coll Nutr 9: 58–64, 1990.
   PubMedGoogle Scholar
• Caddell JL: Magnesium therapy in premature neonates with apnea neonatorum. J Am Coll Nutr 7: 5–16, 1988. [erratum in J Am Coll Nutr 7:189, 1988].
   PubMed Web of Science ®Google Scholar
• Caddell JL: Reply to an editorial concerning magnesium therapy in premature infants with apnea neonatorum. J Am Coll Nutr 7: 185–191, 1988.
   Web of Science ®Google Scholar
• Caddell JL: Magnesium therapy in infants with postneonatal apnea. Magnesium 7: 103–116, 1988.
   Google Scholar
• Caddell JL: Hypothesis: the role of magnesium deficiency in the idiopathic respiratory distress syndrome of prematurity; links between RDS and sudden infant death syndrome. (Abstract) J Am Coll Nutr 11: 627, 1992.
   Google Scholar
• Altura BT, Altura BT, Carelle A, Turlapaty DMV Prasad: Hypomagnesemia and vasoconstriction: possible relationship to etiology of sudden death ischemic disease and hypertensive vascular disease. Artery 9: 212–213, 1981.
   PubMedGoogle Scholar
• Altura BM, Altura BT: New perspectives on the role of magnesium on the pathophysiology of the cardiovascular system. I. Clinical aspects. Magnesium 4: 226–244, 1985.
   PubMedGoogle Scholar
• Seelig MS: Cardiovascular consequences of magnesium deficiency and loss; pathogenesis, prevalence and manifestations - magnesium and chloride loss in refractory potassium repletion. Am J Cardiol 63: 4G–21G, 1989.
   PubMed Web of Science ®Google Scholar
• Altura BM: Calcium antagonist properties of magnesium: implication for antimigraine actions. (Editorial) Magnesium 4: 169–175, 1985.
   PubMedGoogle Scholar
• Swanson DR: Migraine and magnesium: eleven neglected connections. Perspectives in Biol & Med 31: 526–557, 1988.
   PubMed Web of Science ®Google Scholar
• Weaver K: Magnesium and migraine (Letter) Headache 30: 168, 1990.
   Google Scholar
• Rotton WN, Sachtleben MR, Friedman EA: Migraine and eclampsia. Obstet Gynecol 14: 322–330, 1959.
   PubMed Web of Science ®Google Scholar
• Hannington E: Migraine, a blood disorder. Lancet 2: 501–503, 1978.
   Google Scholar
• Ising H, Nawroth H, Guenther T: Accelerated aging of rats by Mg deficiency and noise-stress. Magnesium Bull 3: 142–145, 1981.
   Google Scholar
• Franz K: Hearing thresholds of rats fed different levels of magnesium for two weeks. (Abstract) J Am Coll Nutr 11: 612, 1992.
   Google Scholar
• Ising H: Interaction of noise-induced stress and magnesium. Artery 9: 205–211, 1981.
   PubMedGoogle Scholar
• Ising H, Handrock M, Guenther T, Fischer R, Combrowski: Increased noise trauma in guinea pigs through magnesium deficiency. Arch Otorhinolaryngol 236: 139–146, 1982.
   PubMedGoogle Scholar
• Guenther T, Ising H, Joachim Z: Biochemical mechanisms affecting susceptibility to noise-induced hearing loss. Am J Otol 10: 36–41, 1989.
   Google Scholar
• Joachim Z, Babisch W, Ising H, Guenther T, Handrock M: Dependence of noise-induced hearing loss upon perilymph magnesium concentration. J Acoust Soc Am 7: 104–108, 1983.
   Google Scholar
• Heroux O, Peter D, Heggtveit A: Long-term effect of sub-optimal dietary magnesium on magnesium and calcium contents of organs, on cold tolerance and on lifespan, and its pathological consequences in rats. J Nutr 107: 1640–1652, 1977.
   Google Scholar
• Keys A, Brozek J, Henschel A et al.: “The Biology of Human Starvation.” Minneapolis: Univ Minnesota Press, pp 185–186, 200–202, 1950.
   Google Scholar
• Zimmer R, Weill J, Dubois M: The nutritional situation in the camps of the unoccupied zone of France in 1941 and 1942 and its consequences. N Engl J Med 230: 303–314, 1944.
   Google Scholar
• Mellinghoff K, Van Lessen W: [Magnesium-calcium balance in starvation.] Dtsche Arch klin Med 194: 285–293, 1949. (in German)
   Google Scholar
• DeLeeuw IH, vanGaal L, Vanroelen W: Magnesium and obesity: Magnesium and obesity; effects of treatment on magnesium and other parameters. Magnesium 6: 40–47, 1987.
   Google Scholar
• Sunderman FW: Studies in serum electrolytes. XIV. Changes in blood and body fluids in prolonged fasting. Am J Clin Path 17: 169–180, 1947.
   Google Scholar
• Consolazio CF, Matoush LO, Johnson HL, Nelson RA, Krzywick HJ: Metabolic aspects of acute starvation in normal humans (10 days). Am J Clin Nutr 20: 672–683, 1967.
   PubMed Web of Science ®Google Scholar
• Drenick EJ, Hunt IF, Swendseid ME: Magnesium depletion during prolonged fasting of obese males. J Clin Endocrinol 29: 1341–1348, 1969.
   Google Scholar
• Cubberley PT, Polster SA, Schulman CI: Lactic acidosis and death after the treatment of obesity by fasting. N Engl J Med 272: 628–630, 1965.
   Google Scholar
• Lindeman RD: Nutritional influences on magnesium homeostasis with emphasis on renal factors. In Cantin M, Seelig MS (eds): “Magnesium In Health And Disease.” (Proc of 2nd Intl Sympos on Magnesium, Quebec, 1976) New York: Spectrum Press, pp 381–399, 1980.
   Google Scholar
• Garnett ES, Barnard DL, Ford J, Goodbody RA, Woode-House MA: Gross fragmentation of cardiac myofibrils after therapeutic starvation for obesity. Lancet 1: 914–916, 1969.
   PubMed Web of Science ®Google Scholar
• Heggtveit HA, Herman L, Mishra RK: Cardiac necrosis and calcification in experimental magnesium deficiency. Am J Path 45: 757–782, 1964.
   PubMed Web of Science ®Google Scholar
• Michiel RR, Sneider JS, Dickstein RA, Hayman H, Eich RH: Sudden death in a patient on a liquid protein diet. N Engl J Med 198: 1005–1007, 1978.
   Google Scholar
• Frattali VP: Deaths associated with the liquid protein diet. Natl Clearing House for Poison Control Centers Bull 23: 4–11, 1979.
   Google Scholar
• Licata AA, Lantigua R, Amatruda J, Lockwood D: Adverse effects of liquid protein fast on the handling of magnesium, calcium and phosphorus. Am J Med 71: 767–772, 1981.
   PubMed Web of Science ®Google Scholar
• Licata AA: Magnesium handling during a liquid protein fast. J Am Coll Nutr 2: 315, 1983.
   Google Scholar
• Classen HG: Stress and magnesium. Artery 9: 182–189, 1981.
   PubMedGoogle Scholar
• Mangler B, Fischer G, Classen HG: The influence of magnesium deficiency on the development of gastric stress ulcers in rats. Magnesium Bull 4: 9–12, 1982.
   Google Scholar
• Classen HG: Stress and magnesium with special regard to the gastrointestinal tract. In Itokawa Y, Durlach J (eds): “Magnesium In Health And Disease.” London: John Libbey Press, pp 271–278, 1989.
   Google Scholar
• Nowitzki S, Lehner M, Schimatschek HG, Classen HG: [Marginal magnesium deficiency in children with acute abdominal pain.] Magnesium Bull 10: 114–118, 1988. (in German)
   Google Scholar
• Mozsik G, Garamszegi M, Javor T, Nagy L, Patty I, Suto G, Vincze A: A biochemical and pharmacological approach to the genesis of ulcer disease II. A model study of stress-induced injury to gastric mucosa in rats. Ann NY Acad Sci 597: 264–281, 1990.
   Google Scholar
• Wacker WEC: Magnesium And Man. Cambridge, MA: Harvard Univ Press, 1980.
   Google Scholar
• Guenther T: Biochemistry and pathobiochemistry of magnesium. Artery 9: 167–181, 1981.
   PubMedGoogle Scholar
• Belanger LF, Van Erkel GA, Jakerow A: Behavior of the dermal mast cells in magnesium deficient rats. Science 126: 29–30, 1957.
   Google Scholar
• Bois P, Gascon A, Beaulnes A: Histamine-liberating effect of magnesium deficiency in the rat. Nature 197: 501–502, 1963.
   PubMed Web of Science ®Google Scholar
• Hungerford GF: Role of histamine in producing the eosinophilia of magnesium deficiency. Proc Soc Exp Biol Med 115: 182–185, 1964.
   PubMed Web of Science ®Google Scholar
• Haury VG: Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulfate. J Lab Clin Med 26: 340–344, 1940.
   Google Scholar
• Chyrek-Borowska S, Obrzut D, Hofman J: The relation between magnesium, blood histamine level and eosinophilia in the acute stage of the allergic reactions in humans. Arch Immunol Ther Exp (Warsz) 26: 709–712, 1978.
   PubMed Web of Science ®Google Scholar
• Lehr D: Studies on the Cardiotoxicity of alpha- and beta-adrenergic amines. In Balazs T (ed): “Cardiac Toxicology.” Boca Raton, FL: CRC Press Inc, pp 75–112, 1981.
   Google Scholar
• Chevalier B, le-Heuzey JY, Colombel B, Lavergne T, Guize L, Rozensztajn L, Valty J: [Ventricular tachycardia during theophylline overdose. Apropos of a case of reduction by magnesium chloride.] Arch Mal Coeur 83: 569–573, 1990. (in French)
   Google Scholar
• Golf SW, Enzinger D, Temme H, Graef V, Katz N, Roka L, Friemann E, Lasch H-G, Friemann S, Tross H, Morr H: Effects of magnesium in theophylline treatment of chronic obstructive lung disease. In Lasserre B, Durlach J (eds): “Magnesium - A Relevant Ion.” London: John Libbey Press, pp 443–451, 1991.
   Google Scholar
• Shannon M: Predictors of major toxicity after theophylline overdose. Ann Intern Med 119: 1162–1167, 1993.
   Google Scholar
• Rosello JC, Pla JC: [Magnesium sulfate in asthma crisis.] Prensa Med Argent 23: 1677–1680, 1936. (in Spanish)
   Google Scholar
• Haury VG: The bronchodilator action of magnesium and its antagonistic action (dilator action) against pilocarpine, histamine, and barium chloride. J Pharmacol 64: 58–64, 1938.
   Google Scholar
• Vidal-Freyre A: [Magnesium and allergy.] In Durlach J (ed): Proc 1st Intl Mg Sympos, Vittel, France, 1971. pp 415–416, 1973. (In French)
   Google Scholar
• Brunner EH, Delabroise AM, Haddad ZH: Effect of parenteral magnesium on pulmonary function, plasma cAMP, and histamine in bronchial asthma. J Asthma 22: 3–11, 1985
   PubMed Web of Science ®Google Scholar
• Rolla G, Bucca C, Bugiani M, Arossa W, Spinaci S: Reduction of histamine-induced bronchoconstriction by magnesium in asthmatic subjects. Allergy 42: 186–188, 1987.
   PubMed Web of Science ®Google Scholar
• Rolla G, Bucca C, Caria E, Arossa W, Bugiani M, Cesano L, Caropreso A: Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. Ann Allergy 61: 388–391, 1988.
   PubMedGoogle Scholar
• Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T: Bronchodilating effect of magnesium sulfate in bronchial asthma. JAMA 257: 1076–1078, 1988.
   Google Scholar
• Rolla G, Bucca C, Caria E: Dose-related effect of inhaled magnesium sulfate on histamine bronchial challenge in asthmatics. Drugs Exp Clin Res 14: 609–612, 1988.
   Google Scholar
• McNamara RM, Spivey WH, Skobeloff E, Jacubowitz S: Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma. Ann Emerg Med 18: 197–199, 1989.
   Google Scholar
• Skobeloff EM, Spivey WH, McNamara RM, Greenspan L: Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 262: 1210–1213, 1989.
   PubMed Web of Science ®Google Scholar
• Rolla G, Bucca C, Caria E: The effect of magnesium on bronchial hyperreactivity of asthmatics. (Abstract) Magnesium Res. 2: 82, 1989.
   Google Scholar
• Rolla G, Bucca C: Hypomagnesemia and bronchial hyperactivity. A case report. Allergy 44: 519–521, 1989.
   PubMed Web of Science ®Google Scholar
• Noppen M, Vanmaele L, Impens N, Schandevyl W: Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma. Chest 97: 373–376, 1990.
   PubMed Web of Science ®Google Scholar
• Rolla G, Bucca C, Bugiani M, Oliva A, Branciforte L: Hypomagnesemia in chronic obstructive disease; effect of therapy. Magnes Trace Elem 9: 132–136, 1990.
   PubMedGoogle Scholar
• Spivey WH, Greenspon L, McNamara R, Skobeloff EJ: JAMA 263: 517, 1990.
   Google Scholar
• Kuitert LM, Kletchko SL: Intravenous magnesium sulfate in acute, life-threatening asthma. Ann Emerg Med 21: 1243–1245, 1991.
   Google Scholar
• Neves MC, Brito U, Miguel MJP, Vivente O, Barros F, Silva JR: Evaluation of Mg2+ aspartate HCl in asthmatic crises. Magnesium Bull 13: 88–93, 1991.
   Google Scholar
• Okayama H, Okayama M, Aikawa T, Sasaki M, Takishima T: Treatment of status asthmaticus with intravenous magnesium sulfate. J Asthma 28: 11–17, 1991.
   PubMed Web of Science ®Google Scholar
• Hauser SP, Braun PH: Intravenous magnesium in asthmatic patients. A clinical trial and review of the literature. In Lasserre B, Durlach J (eds): “Magnesium - A Relevant Ion. London: John Libbey Press, pp 435–442, 1991.
   Google Scholar
• Manzke H, Thiemeier M, Elster P, Lemke J: [Magnesium sulfate as adjuvant in beta-2-sympathicomimetic inhalation therapy of bronchial asthma.] Pneumologie 44: 1190–1192, 1990. (In German)
   Google Scholar
• Kufs WM: Intravenous magnesium sulfate in acute asthma. (Letter) JAMA 263: 516–517, 1990.
   Google Scholar
• Green SM, Rothrock SG: Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med 21: 260–265, 1992.
   Google Scholar
• Tiffany BR, Berk WA, Todd IK, White SR: Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations. Chest 104: 831–834, 1993.
   PubMedGoogle Scholar
• Skobeloff EM, McNamara RM: Intravenous magnesium for acute asthma. (Letter) Ann Emerg Med 22: 617–618, 1993.
   Google Scholar
• Spivey WH: Intravenous magnesium for acute asthma. (Letter) Ann Emerg Med 22: 617, 1993.
   Google Scholar
• Fesmire FM: Intravenous magnesium for acute asthma. (Letter) Ann Emerg Med 22: 616–617, 1993.
   Google Scholar
• Classen HG, Scherb H, Scherb I: [In-vitro studies on the broncholytic efficacy of magnesium.] Magnesium Bull 11: 80–84, 1989. (In German)
   Google Scholar
• Spivey WH, Skobeloff EM, Levin RM: Effect of magnesium chloride on rabbit bronchial smooth muscle. Ann Emerg Med 19: 1107–1112, 1990.
   PubMedGoogle Scholar
• Lindeman KS, Hirshman CA, Freed: Effect of magnesium sulfate on bronchoconstriction in the lung periphery. J Appl Physiol 66: 2527–2532, 1989.
   Google Scholar
• Mathew R, Altura BM: The role of magnesium in lung diseases: asthma, allergy and pulmonary hypertension. Magnes Trace Elem 10: 220–228, 1991–92
   Google Scholar
• Landon RA, Young EA: Role of magnesium in regulation of lung function. J Am Diete Assoc 93: 674–677, 1993.
   PubMed Web of Science ®Google Scholar
• Keen CL, Lowney P, Gershwin ME, Hurley LS, Stern JS: Dietary magnesium intake influences exercise capacity and hematologic parameters in rats. Metabolism 36: 788–793, 1987.
   PubMedGoogle Scholar
• Lowney P, Gershwin ME, Stern JS, Keen CL: Magnesium intake and endurance capacity in rats. Fed Proc 46: 1020, 1987.
   Google Scholar
• Lowney P, Gershwin ME, Hurley LS, Stern JS, Keen CL: The effect of variable magnesium intake on potential factors influencing endurance capacity. Biol Trace Elem Res 16: 1–18, 1988.
   Google Scholar
• Gershwin ME, Lowney P, Hurley LS, Keen CL: Effect of variable magnesium intake on hematological and immunological parameters in the rat. (Abstract) Magnesium 6: 153, 1987.
   Google Scholar
• Lowney P, Stern JS, Gershwin ME, Keen CL: Magnesium deficiency and blood 2,3-diphosphoglycerate concentrations in sedentary and exercised male Osborne-Mendel rats. Metabolism 39: 837–841, 1990.
   Google Scholar
• Laires MJ, Rayssiguier Y, Guezennec CY, Alves F, Halpern MJ: Effect of magnesium deficiency on exercise capacity in rats. Magnesium Res 2: 136, 1989.
   Google Scholar
• Hirneth HD, Classen HG: Swimming performance of rats in relation to magnesium intake. Magnesium Res 1: 98–99, 1988.
   Google Scholar
• Refsum HE, Meen HD, Stromme S: Whole blood, serum and erythrocyte magnesium concentrations after repeated heavy exercise of long duration. Scand J Clin Lab Invest 32: 123–127, 1973.
   PubMed Web of Science ®Google Scholar
• Casoni I, Guglielmin C, Graziano L, Reali MG, Mazzotta D, Abbasciano V: Changes of magnesium concentrations in endurance athletes. Intl J Sports Med 11: 234–237, 1990.
   PubMed Web of Science ®Google Scholar
• Hoffmann G, Boehmer D: [Magnesium concentrations in whole blood, serum and erythrocytes in trained long distance runners before and after 25 kilometer race with and without four weeks oral electrolyte intake.] Magnesium Bull 10: 56–63, 1988. (In German)
   Google Scholar
• Lijnen P, Hespel P, Fagard R, Lysens R, Vanden-Eynde E, Amery A: Erythrocyte, plasma and urinary magnesium in men before and after a marathon. Europ J Appl Physiol 58: 252–256, 1988.
   Web of Science ®Google Scholar
• Mader A, Hartmann U, Fischer HG, Reinhards-Mader G, Bohnert KJ, Hollmann W: [The substitution of magnesium during towing team's altitude training in the offing of the Olympic games-results of a controlled study.] Magnesium Bull 12: 69–78, 1990. (In German)
   Google Scholar
• Jooste PL, Wolfswinkel JM, Schoeman JJ, Strydom NB: Epileptic-Type Convulsions and Magnesium Deficiency. Aviation Space Environm Med 50: 732–745, 1979.
   Google Scholar
• Bertschat F, Golf S, Riediger H, Graef V, Ising H: Protective effects of magnesium on release of proteins from muscle cells during a marathon run. Magnesium Bull 8: 310–313, 1986.
   Google Scholar
• Stendig-Lindberg G, Epstein Y, Galun E, Shapiro Y, Graff E, Schonberger E: Persistent hypomagnesaemia following strenuous effort. (Abstract) Magnesium 4: 212–213, 1985.
   Google Scholar
• Stendig-Lindberg G, Shapiro Y, Epstein Y, Galun E, Schonberger E, Graff E, Wacker WEC: Changes in serum magnesium concentration after strenuous exercise. J Am Coll Nutr 6: 35–40, 1987.
   PubMed Web of Science ®Google Scholar
• Stendig-Lindberg G, Shapiro Y, Graff E, Schonberger E, Wacker WEC: Delayed metabolic changes after strenuous exertion in trained young men. Magnesium Res 2: 211–218, 1989.
   Google Scholar
• Stendig-Lindberg G, Wacker WE, Shapiro Y: Long term effects of peak strenuous effort on serum magnesium, lipids, and blood sugar in apparently healthy young men. Magnes Res 4: 59–65, 1991.
   Google Scholar
• Boehmer D: [Reaction on magnesium serum level of athletic performance.] Magnesium Bull 1: 109–110, 1979. (In German)
   Google Scholar
• Ansquer D: The influence of sports activity on magnesium metabolism. PhD Thesis, Abstr in Magnesium Res. 1: 122, 1988.
   Google Scholar
• Deuster PA, Dolev E, Kyle SB, Anderson RA, Schoomaker EB: Magnesium homeostasis during high-intensity anaerobic exercise in men. J Appl Physiol 62: 545–550, 1987.
   PubMed Web of Science ®Google Scholar
• Lukaski HC, Bolonchuk WW, Klevay LM, Milne DB, Sandstead HH: Maximal oxygen consumption as related to magnesium, copper, and zinc nutriture. Am J Clin Nutr 37: 407–415, 1983.
   PubMed Web of Science ®Google Scholar
• Conn CA, Schemmel RA, Smith BW, Ryder E, Heusner WW, Ku PK: Plasma and erythrocyte magnesium concentrations and correlations with maximum oxygen consumption in nine- to twelve-year-old competitive swimmers. Magnesium 7: 27–36, 1988.
   PubMedGoogle Scholar
• Laires MJ, Alves F, Halpern MJ: Changes in serum and erythrocyte magnesium and blood lipids after distance swimming. Magnesium Res 1: 219–222, 1988.
   PubMedGoogle Scholar
• Ahlborg B, Ekelund LG, Nilsson CG: Effect of potassium-magnesium-aspartate on the capacity for prolonged exercise in man. Acta Physiol Scand 74: 238–245, 1968.
   PubMedGoogle Scholar
• Bergstrom J, Guarnieri G, Hultman E: Carbohydrate metabolism and electrolyte changes in human muscle tissue during heavy work. J Appl Physiol 30: 122–125, 1971.
   PubMed Web of Science ®Google Scholar
• Boehmer D: [Influence of endurance training on sodium, potassium and magnesium homeostasis in swimmers: girls and boys]. Magnesium Bull 1: 74–76, 1979. (In German)
   Google Scholar
• deHaan A, vanDoorn JE, Westra HG: Effects of potassium + magnesium aspartate on muscle metabolism and force development during short intensive static exercise. Intl J Sports Med 6: 44–49, 1985.
   Google Scholar
• Veith J, Beuker F, Spannaus W: Magnesium-substitution in runners and endurance athletes. Magnesium Res 1: 99, 1988.
   Google Scholar
• Terblanche S, Noakes TD, Dennis SC, Marais D, Eckert M: Failure of magnesium supplementation to influence marathon running performance or recovery in magnesium-replete subjects. Intl J Sport Nutr 2: 154–164, 1992.
   PubMed Web of Science ®Google Scholar
• Wodick R, Grunert-Fuchs M: [The influence of long term magnesium administration in different parameters of physical performance.] Magnesium Bull 7: 51–55, 1985. (In German)
   Google Scholar
• Golf S, Munch J, Graef V, Temme H, Brustle A, Roka L, Beuther G, Heinz N, Buhl C, Nowacki PE: [Influence of magnesium supplementation over 4 weeks on lactate elimination of rowers during exhausting competition-specific performance.] Magnesium Bull 10: 124–130, 1988. (In German)
   Google Scholar
• Pohlmann U, Schmidt M, Golf S, Graef V, Roka L, Temme H, Riediger H, Neppel H, Bortz C Baumgaertner: [Effects of magnesium on hemostasis in competitive swimmers before and after maximal exercise.] Magnesium Bull 12: 47–51, 1990. (In German)
   Google Scholar
• Food and Nutrition Board, Natl Res Council: “Recommended Dietary Allowances 9th Ed. Washington, DC: Natl Acad Press, pp 134–136, 1980.
   Google Scholar
• Moffatt RJ: Dietary status of elite female high school gymnasts: inadequacy of vitamin and mineral intake. J Am Diet Assoc 84: 1361–1363, 1984.
   PubMed Web of Science ®Google Scholar
• Deuster PA, Kyle SB, Moser PB, Vigersky RA, Singh A, Schoomaker EB: Nutritional survey of highly trained women runners. Am J Clin Nutr 44: 954–962, 1986.
   PubMed Web of Science ®Google Scholar
• Boggio V, Guilland JC, Moreau D, Durlach J, Klepping J: Dietary magnesium intake among male athletes in France. Magnesium Bull 8: 275, 1986.
   Google Scholar
• Singh A, Deuster PA, Day BA, DeBolt JE, Doubt JT. Mineral and electrolyte status of U.S. Navy divers. Fed Proc 46: 592, 1987.
   Google Scholar
• Keith RE, O'Keeffe KA, Alt LA, Young KL: Urinary status of untrained female cyclists. J Am Diet Assoc 89: 1620–1623, 1989.
   Google Scholar
• Singh A, Day BA, DeBolt JE, Trostmann UH, Bernier LL, Deuster PA: Magnesium, zinc, and copper status of US Navy SEAL trainees. Am J Clin Nutr 49: 695–700, 1989.
   PubMed Web of Science ®Google Scholar
• Singh A, Deuster PA, Day BA, Moser-Veillon PB: Dietary intakes and biochemical markers of selected minerals: comparison of highly trained runners and untrained women. J Am Coll Nutr 9 65–75, 1990.
   PubMedGoogle Scholar
• Durlach J: Recommended dietary amounts of magnesium: Mg RDA. Magnesium Res 2: 195–203, 1989.
   PubMedGoogle Scholar
• Seelig MS: Adverse stress reactions in magnesium deficiency; preventive and therapeutic implications. (Abstract) 11: 609, 1992.
   Google Scholar
• Rayssiguier Y, Gueennec CY, Durlach J: New experimental and clinical data on the relationship between magnesium and sport. Magnes Res 3: 93–102, 1990.
   PubMedGoogle Scholar
• Niemack EA, Stoeckli F, Husmann E, Sonderegger J, Classen HG, Helbig J: [The effect of magnesium aspartate hydrochloride on cannibalism, transport stress and electrolyte content in the heart of pigs.] Magnesium Bull 1: 195–198, 1979. (In German)
   Google Scholar
• Schumm H: [The effect of magnesium-1-aspartate-hydrochloride on transport losses with fattening pigs and piglets as well as on the meat quality of carcasses.] Magnesium Bull 6: 23–29, 1984. (In German)
   Google Scholar
• Niemack EA: [Magnesium. Mineral-trace element-therapeutic substance? A review.] Schweiz Arch Tierheilkd 127: 597–604, 1985. (In German)
   Google Scholar
• Grashorn M, Schimatschek HF, Hickl R, Scholtyssek S, Classen HG: [The influence of monomagnesium-L-aspartate-hydrochloride on the “sudden death syndrome” and electrolyte distribution in broilers.] Magnesium Bull 10: 9–14, 1988. (In German)
   Google Scholar
• Rasmussen HS: Justification for intravenous magnesium therapy in acute myocardial infarction. Magnesium Res 1: 59–73, 1988.
   PubMedGoogle Scholar
• Rasmussen HS: Clinical intervention studies on magnesium in myocardial infarction. Magnesium 8: 316–325, 1989.
   Google Scholar
• Shechter M: Beneficial effects of magnesium in acute myocardial infarction. A review of the literature. Magnesium Bull 12: 1–6, 1990.
   Google Scholar
• Woods KL, Fletcher S, Roffe C, Haider Y: Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339: 1553–1558, 1992.
   PubMed Web of Science ®Google Scholar
• Woods KL, Fletcher S: Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 343: 816–819, 1994.
   PubMed Web of Science ®Google Scholar
• Casscells W: Magnesium and myocardial infarction. Lancet 343: 807–809, 1994.
   Google Scholar
• NIH Consensus Development Conference on Optimal Calcium Intake. Bethesda, MD, June 6–8, 1994.
   Google Scholar
• Karppannen H, Pennanen R, Passinen L: Minerals, coronary heart disease and sudden coronary death. Adv Cardiol 25: 9–24, 1978.
   PubMedGoogle Scholar
• Karppannen H: Epidemiologic evidence for considering magnesium deficiency as a risk factor for cardiovascular diseases. Magnesium Bull 12: 80–86, 1990.
   Google Scholar